Details for Patent: 9,259,423
✉ Email this page to a colleague
Which drugs does patent 9,259,423 protect, and when does it expire?
Patent 9,259,423 protects LATUDA and is included in one NDA.
Protection for LATUDA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has eight patent family members in five countries.
Summary for Patent: 9,259,423
| Title: | Method of treatment for mental disorders |
| Abstract: | The invention relates to a medicament or a method for treating mental disorders, in detail, ADHD comprising lurasidone, or a combination of lurasidone and a D.sub.4 receptor agonist. |
| Inventor(s): | Ikeda; Kazuhito (Osaka, JP), Ishiyama; Takeo (Osaka, JP) |
| Assignee: | Sumitomo Dainippon Pharma Co., Ltd. (Osaka, JP) |
| Application Number: | 13/555,044 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,259,423 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,259,423
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-003 | Dec 7, 2011 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-001 | Oct 28, 2010 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-005 | Jul 12, 2013 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-002 | Oct 28, 2010 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-004 | Apr 26, 2012 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,259,423
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2011-033453 | Feb 18, 2011 |
International Family Members for US Patent 9,259,423
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2814828 | ⤷ Try a Trial | |||
| China | 103180315 | ⤷ Try a Trial | |||
| European Patent Office | 2638038 | ⤷ Try a Trial | |||
| Japan | 2013541582 | ⤷ Try a Trial | |||
| Japan | 2016094440 | ⤷ Try a Trial | |||
| Japan | 5855670 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
